# Biomarin Pharmaceutical Inc: Form 8-K, filed Jun 4, 2026

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K
- Filed: 2026-06-04
- Accepted by EDGAR: Jun 4, 2026, 16:24 ET
- Period: 2026-06-02
- Accession: 0001628280-26-040812
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000162828026040812/bmrn-20260602.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000162828026040812/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000162828026040812/bmrn-20260602.htm

Filed Jun 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-040812. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.